Dudediligence.

Aurinia Pharmaceuticals Inc

AUPHNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$67.8MSep ’24$59.9MDec ’24$62.5MMar ’25$70.0MJun ’25$73.5MSep ’25$77.1MDec ’25$77.7MMar ’26$83.2MJun ’26
Net income, by quarter
$14.3MSep ’24$1.4MDec ’24$23.3MMar ’25$21.5MJun ’25$31.6MSep ’25$210.8MDec ’25$34.4MMar ’26$37.4MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$45.6M$134.0M$175.5M$235.1M$283.1M
Gross profit$44.5M$128.4M$161.4M$206.9M$250.4M
Operating income−$180.7M−$111.5M−$91.7M−$4.7M$104.9M
Net income−$181.0M−$108.2M−$78.0M$5.8M$287.2M
Operating cash flow−$157.7M−$79.5M−$33.5M$44.4M$135.7M
Free cash flow−$158.0M−$79.8M−$34.2M$44.1M$135.4M
Cash$231.6M$94.1M$48.8M$83.4M$80.2M
Shares outstanding141.6M142.3M143.8M140.9M132.3M